Samsung Bioepis has appointed Kyung-Ah Kim as president and CEO, succeeding Christopher Hansung Ko. The leadership change ...

Ethiopia, with a 2-3 per cent diabetes prevalence rate, ranks among the top four countries in sub-Saharan Africa for adult ...

Generic and biosimilar drugs are often preferred over the brand name version due to their cheaper prices. Generics are exact ...

The study findings demonstrate that the aflibercept biosimilar MYL-1701P is as effective and safe as the reference ...

India has firmly established itself as the world's major producer of generic drugs. It is currently ranked third in ...

Integrating IT with pharmaceuticals will further strengthen its role, paving the way for dominance in biologics and ...

The Centers for Medicare & Medicaid Services is attempting to cover anti-obesity medications under Medicare Part D and ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

AbbVie’s promising pipeline and 3.95% dividend yield offer growth potential. Read why ABBV stock could thrive despite the Emraclidine trial failure.

For our methodology, we used a stock screener and selected healthcare stocks that had an RSI below 30, mid-market cap, and ...

Dividend stocks provide investors with reliable passive income. These four health care picks look like outstanding ideas now.

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...